CCNE1 is a potential target of Metformin for tumor suppression of ovarian high-grade serous carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Cell Cycle"
DOI: 10.1080/15384101.2022.2109362
Abstract: ABSTRACT High-grade serous ovarian cancer (HGSOC) is the most common and malignant type of ovarian cancer, accounting for 70%–80% of mortality. However, the treatment of HGSOC has improved little in the past few decades. Metformin… read more here.
Keywords: target metformin; hgsoc; ccne1; treatment ... See more keywords